European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares
INGELHEIM, Germany -- (BUSINESS WIRE) -- The European Commission (EC) granted a conditional marketing authorization for Boehringer Ingelheim』s spesolimab as first in class treatment for GPP ......